The store will not work correctly when cookies are disabled.
2-methoxy-1,3-dinitroanthracene-9,10-dione
ID: ALA2332990
PubChem CID: 71720652
Max Phase: Preclinical
Molecular Formula: C15H8N2O7
Molecular Weight: 328.24
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1c([N+](=O)[O-])cc2c(c1[N+](=O)[O-])C(=O)c1ccccc1C2=O
Standard InChI: InChI=1S/C15H8N2O7/c1-24-15-10(16(20)21)6-9-11(12(15)17(22)23)14(19)8-5-3-2-4-7(8)13(9)18/h2-6H,1H3
Standard InChI Key: WNJOXEVUSWPWTO-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
27.8037 -22.0889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8026 -22.9084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5106 -23.3174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5088 -21.6800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2175 -22.0853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2163 -22.9059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9225 -23.3150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9248 -21.6737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6355 -22.0873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6339 -22.9043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3395 -23.3125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0472 -22.9048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0449 -22.0846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3387 -21.6801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9248 -20.8565 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.9219 -24.1322 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.7553 -23.3127 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.7561 -24.1299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3387 -24.1297 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.0457 -24.5411 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.6303 -24.5398 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.7532 -21.6718 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.7507 -20.8546 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.4622 -22.0782 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 8 1 0
6 7 1 0
7 10 1 0
9 8 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
8 15 2 0
7 16 2 0
12 17 1 0
17 18 1 0
11 19 1 0
19 20 2 0
19 21 1 0
22 23 2 0
22 24 1 0
13 22 1 0
M CHG 4 19 1 21 -1 22 1 24 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 328.24 | Molecular Weight (Monoisotopic): 328.0332 | AlogP: 2.29 | #Rotatable Bonds: 3 |
Polar Surface Area: 129.65 | Molecular Species: NEUTRAL | HBA: 7 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.64 | CX LogD: 2.64 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.53 | Np Likeness Score: -0.11 |
References
1. Castro-Castillo V, Suárez-Rozas C, Castro-Loiza N, Theoduloz C, Cassels BK.. (2013) Annulation of substituted anthracene-9,10-diones yields promising selectively antiproliferative compounds., 62 [PMID:23454511] [10.1016/j.ejmech.2013.01.049] |